Safe and well-tolerated treatment with ivabradine in systemic sclerosis affected by pulmonary hypertension

Clin Res Cardiol. 2012 Jul;101(7):593-4. doi: 10.1007/s00392-012-0437-1. Epub 2012 Mar 2.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Anti-Arrhythmia Agents / adverse effects
  • Anti-Arrhythmia Agents / therapeutic use*
  • Antihypertensive Agents / therapeutic use
  • Benzazepines / adverse effects
  • Benzazepines / therapeutic use*
  • Cardiac Catheterization
  • Drug Therapy, Combination
  • Echocardiography, Doppler
  • Exercise Test
  • Exercise Tolerance / drug effects
  • Familial Primary Pulmonary Hypertension
  • Female
  • Heart Rate / drug effects*
  • Humans
  • Hypertension, Pulmonary / diagnosis
  • Hypertension, Pulmonary / drug therapy*
  • Hypertension, Pulmonary / etiology
  • Hypertension, Pulmonary / physiopathology
  • Ivabradine
  • Middle Aged
  • Pulmonary Artery / drug effects
  • Pulmonary Artery / physiopathology
  • Pulmonary Wedge Pressure / drug effects
  • Scleroderma, Systemic / complications*
  • Time Factors
  • Treatment Outcome

Substances

  • Anti-Arrhythmia Agents
  • Antihypertensive Agents
  • Benzazepines
  • Ivabradine